Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab

BACKGROUND AND OBJECTIVES: B cell significance in ANCA disease pathogenesis is underscored by the finding that ANCA alone can cause disease in mouse models and by the effectiveness of rituximab as therapy in ANCA-small vessel vasculitis (ANCA-SVV). To avoid infections and adverse events from therapy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bunch, Donna O’Dell, McGregor, JulieAnne G., Khandoobhai, Nirmal B., Aybar, Lydia T., Burkart, Madelyn E., Hu, Yichun, Hogan, Susan L., Poulton, Caroline J., Berg, Elisabeth A., Falk, Ronald J., Nachman, Patrick H.
Format:	Artigo
Language:	Inglês
Published:	American Society of Nephrology 2013
Subjects:	Original Articles
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3586963/ https://ncbi.nlm.nih.gov/pubmed/23293123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03950412
Tags:	Add Tag No Tags, Be the first to tag this record!

Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab

Similar Items